Mario Boccadoro

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Mario Boccadoro

Dec 10, 2024, 13:59 | Opinion

Rahul Banerjee: Safety run-in for Teclistamab and Lenalidomide maintenance after ASCT

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a post on X: “MajesTEC-4!…

Jul 21, 2024, 12:01 | Insight

Myeloma Paper of the Day, July 21st, suggested by Robert Orlowski

Robert Orlowski shared on X: “Myeloma Paper of the Day: RPL5 loss, APOBEC mutagenesis, & gain…

Jul 20, 2024, 21:26 | Blog

Francesco Maura: Why myeloma relapses after anti-CD38 antibodies

Francesco Maura, Assistant Professor at Sylvester Comprehensive Cancer Center, shared a post on X: "Happy to…

Jun 11, 2024, 11:27 | Blog

Rahul Banerjee: Excellent multiple myeloma work in Blood Cancer Journal

Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared a post by Mattia D'Agostin,…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023